Table 2.
Treatment group | Seriousness of AE |
Total number of AE reports | Number of animals with reported AEs (% of treatment group)* | Total number of clinical signs reported as AEs | |
---|---|---|---|---|---|
Non-serious | Serious | ||||
Placebo (n = 98) | 35 | 13 | 48 | 33 (33.7) | 64 |
Robenacoxib (n = 95) | 46 | 8 | 54 | 37 (38.9) | 76 |
Total (n = 193) | 81 | 21 | 102 | 70 (36.3) | 140 |
No significant difference between groups (P = 0.46) with Fisher’s exact test in percentage of AE occurrence (yes/no to at least one AE experienced)